These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1980863)

  • 1. Dopaminergic treatments for hyperprolactinaemia.
    Crosignani PG; Ferrari C
    Baillieres Clin Obstet Gynaecol; 1990 Sep; 4(3):441-55. PubMed ID: 1980863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hyperprolactinemia in infertility.
    Crosignani PG
    J Reprod Med; 1999 Dec; 44(12 Suppl):1116-20. PubMed ID: 10649821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinaemia--a clinical study with special reference to long-term follow-up, treatment with dopamine agonists, and pregnancy.
    Rasmussen C
    Ups J Med Sci; 1990; 95(1):1-29. PubMed ID: 1977229
    [No Abstract]   [Full Text] [Related]  

  • 4. Cabergoline treated hyperprolactinaemia results in pregnancy in a bromocriptine intolerant patient after seventeen years of infertility.
    Jones TH; Fraser RB
    Br J Obstet Gynaecol; 1994 Apr; 101(4):349-50. PubMed ID: 7911037
    [No Abstract]   [Full Text] [Related]  

  • 5. Is pregnancy the best treatment for hyperprolactinaemia?
    Crosignani PG; Mattei AM; Scarduelli C; Cavioni V; Boracchi P
    Hum Reprod; 1989 Nov; 4(8):910-2. PubMed ID: 2575622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinaemia.
    Prabhakar VK; Davis JR
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):341-53. PubMed ID: 17889620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment issues in female hyperprolactinaemia.
    Crosignani PG
    Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):152-64. PubMed ID: 16288952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of CV205-502 in patients with hyperprolactinaemia intolerant and/or resistant to bromocriptine.
    Razzaq R; O'Halloran DJ; Beardwell CG; Shalet SM
    Horm Res; 1993; 39(5-6):218-22. PubMed ID: 7906243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of anovulatory infertility.
    Li RH; Ng EH
    Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):757-68. PubMed ID: 22703626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy.
    Ciccarelli E; Grottoli S; Razzore P; Gaia D; Bertagna A; Cirillo S; Cammarota T; Camanni M; Camanni F
    J Endocrinol Invest; 1997 Oct; 20(9):547-51. PubMed ID: 9413809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of pregnancy in patients managed conservatively for hyperprolactinaemia.
    Barton D; Maguiness S; Gordon D; Hadden D; Kennedy L; Sheridan B; Traub A; Harley G; Atkinson B
    Ir Med J; 1987 May; 80(5):147-51. PubMed ID: 3597038
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopaminergic drug therapy in patients with hyperprolactinemia that is difficult to treat.
    Pepperell RJ
    Ann N Y Acad Sci; 1991; 626():431-7. PubMed ID: 1676255
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term follow-up of patients with hyperprolactinaemia.
    Jeffcoate WJ; Pound N; Sturrock ND; Lambourne J
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):299-303. PubMed ID: 8949567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment of hyperprolactinaemic disorders.
    Ferrari C; Crosignani PG
    Hum Reprod; 1986 Dec; 1(8):507-14. PubMed ID: 3546358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
    Prathibha D; Govardhani M; Krishna PT
    J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anovulatory infertility: a report of four cases and literature review.
    Anate M; Olatinwo AW
    Niger J Med; 2001; 10(2):85-90. PubMed ID: 11705066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders: an open, uncontrolled, multicentre study. European Multicentre Cabergoline Study Group.
    Webster J; Piscitelli G; Polli A; D'Alberton A; Falsetti L; Ferrari C; Fioretti P; Giordano G; L'Hermite M; Ciccarelli E
    Clin Endocrinol (Oxf); 1993 Sep; 39(3):323-9. PubMed ID: 7900937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of quality of life in recently post-menopausal women on dopaminergic therapy for pathological hyperprolactinaemia.
    Giusti M; Foppiani L; Penati S; Marugo A; Montini P; Menichini U; Rasore E; Giordano G
    Minerva Endocrinol; 1999 Mar; 24(1):11-9. PubMed ID: 10731741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pregnancy in hyperprolactinemic patients].
    Ventz M; Puhlmann B; Knappe G; Gerl H; Lehmann R; Rohde W
    Zentralbl Gynakol; 1996; 118(11):610-5. PubMed ID: 9082694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prolactin, bromocriptine and gonadal function in women: recent advances. II. Treatment of female hyperprolactinemia and other indications for the use of bromocriptine].
    Buvat J; Buvat-Herbaut M
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(4):509-21. PubMed ID: 6754799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.